Body surface area

Last updated

In physiology and medicine, the body surface area (BSA) is the measured or calculated surface area of a human body. For many clinical purposes, BSA is a better indicator of metabolic mass than body weight because it is less affected by abnormal adipose mass. Nevertheless, there have been several important critiques of the use of BSA in determining the dosage of medications with a narrow therapeutic index, such as chemotherapy.

Contents

Typically there is a 4–10 fold variation in drug clearance between individuals due to differing the activity of drug elimination processes related to genetic and environmental factors. This can lead to significant overdosing and underdosing (and increased risk of disease recurrence). It is also thought to be a distorting factor in Phase I and II trials that may result in potentially helpful medications being prematurely rejected. [1] [2] The trend to personalized medicine is one approach to counter this weakness.

Uses

Examples of uses of the BSA:

There is some evidence that BSA values are less accurate at extremes of height and weight, where Body Mass Index may be a better estimate (for hemodynamic parameters). [3]

Calculation

Various calculations have been published to arrive at the BSA without direct measurement. In the following formulae, BSA is expressed in m 2, weight (or, more properly, mass) W in kg, and height H in cm.

The most widely used is the Du Bois formula, [4] [5] which has been shown to be equally as effective in estimating body fat in obese and non-obese patients, something the Body mass index fails to do. [6]

The Mosteller formula is also commonly used, and is mathematically simpler: [7]

Other formulas for BSA in m2 include:

Haycock [8]
Gehan and George [9]   
Boyd [10]
   or alternatively   
Fujimoto [11]
Takahira [11]
Shuter and Aslani [12]
Lipscombe [13]   
Schlich [14]     (women)
    (men)

For any formula, the units should match. Mosteller pointed out that his formula holds only if the density is treated as a constant for all humans. Lipscombe, following Mosteller's reasoning, observed that the formulas obtained by Fujimoto, Shuter and Aslani, Takahira, and Lipscombe are suggestive of , which is dimensionally correct for the case of constant density. It equals .

A weight-based formula that does not include a square root (making it easier to use) was proposed by Costeff and recently validated for the pediatric age group. It is [4W (kg) + 7]/[90 + W (kg)]. [15] [16]

Average values

Average BSA for children of various ages, for men, and for women, can be estimated using statistical survey data and a BSA formula: [17]

Mean male BSA by age
Age or age groupmetricimperial
Neonate (newborn)0.243m22.612ft2
2 years0.563m26.060ft2
5 years0.787m28.471ft2
10 years1.236m213.304ft2
13 years1.603m217.255ft2
18 years1.980m221.313ft2
20–79 years2.060m222.173ft2
80+ years1.920m220.667ft2
Mean female BSA by age
Age or age groupmetricimperial
Neonate (newborn)0.234m22.519ft2
2 years0.540m25.813ft2
5 years0.771m28.299ft2
10 years1.245m213.401ft2
13 years1.550m216.684ft2
18 years1.726m218.579ft2
20–79 years1.830m219.697ft2
80+ years1.638m217.631ft2

The estimations in the above tables are based weight and height data from the U.S. NCHS National Health and Nutrition Examination Survey (2011-2014). [18]

There was an average BSA of 1.73 m2 for 3,000 cancer patients from 1990 to 1998 in a European Organisation for Research and Treatment of Cancer (EORTC) database. [19]

During 2005 there was an average BSA of 1.79 m2 for 3,613 adult cancer patients in the UK. Among them the average BSA for men was 1.91 m2 and for women was 1.71 m2. [20]

Related Research Articles

<span class="mw-page-title-main">Body mass index</span> Relative weight based on mass and height

Body mass index (BMI) is a value derived from the mass (weight) and height of a person. The BMI is defined as the body mass divided by the square of the body height, and is expressed in units of kg/m2, resulting from mass in kilograms (kg) and height in metres (m).

<span class="mw-page-title-main">Chemotherapy</span> Treatment of cancer using drugs that inhibit cell division or kill cells

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent or it may aim to prolong life or to reduce symptoms. Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.

<span class="mw-page-title-main">Glomerular filtration rate</span> Renal function test

Renal functions include maintaining an acid–base balance; regulating fluid balance; regulating sodium, potassium, and other electrolytes; clearing toxins; absorption of glucose, amino acids, and other small molecules; regulation of blood pressure; production of various hormones, such as erythropoietin; and activation of vitamin D.

Human body weight is a person's mass or weight.

Fluorouracil, sold under the brand name Adrucil among others, is a cytotoxic chemotherapy medication used to treat cancer. By intravenous injection it is used for treatment of colorectal cancer, oesophageal cancer, stomach cancer, pancreatic cancer, breast cancer, and cervical cancer. As a cream it is used for actinic keratosis, basal cell carcinoma, and skin warts.

<span class="mw-page-title-main">Caspofungin</span> Antifungal medication

Caspofungin is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-glucan synthesis to be approved by the United States Food and Drug Administration. Caspofungin is administered intravenously.

Impedance cardiography (ICG) is a non-invasive technology measuring total electrical conductivity of the thorax and its changes in time to process continuously a number of cardiodynamic parameters, such as stroke volume (SV), heart rate (HR), cardiac output (CO), ventricular ejection time (VET), pre-ejection period and used to detect the impedance changes caused by a high-frequency, low magnitude current flowing through the thorax between additional two pairs of electrodes located outside of the measured segment. The sensing electrodes also detect the ECG signal, which is used as a timing clock of the system.

Cardiac index (CI) is a haemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA), thus relating heart performance to the size of the individual. The unit of measurement is litres per minute per square metre (L/min/m2).

<span class="mw-page-title-main">Tesofensine</span> Chemical compound

Tesofensine (NS2330) is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity. Tesofensine was originally developed by a Danish biotechnology company, NeuroSearch, who transferred the rights to Saniona in 2014.

<span class="mw-page-title-main">Lorcaserin</span> Antiobesity drug

Lorcaserin, marketed under the brand name Belviq, was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating a type of serotonin receptor known as the 5-HT2C receptor in a region of the brain called the hypothalamus, which is known to control appetite. It was approved in 2012, and in 2020, it was removed from the market in the United States due to an increased risk of cancer detected in users of Belviq.

<span class="mw-page-title-main">Overweight</span> Above a weight considered healthy

Being overweight or fat is having more body fat than is optimally healthy. Being overweight is especially common where food supplies are plentiful and lifestyles are sedentary.

Lean body mass (LBM), sometimes conflated with fat-free mass, is a component of body composition. Fat-free mass (FFM) is calculated by subtracting body fat weight from total body weight: total body weight is lean plus fat. In equations:

<span class="mw-page-title-main">Obesity-associated morbidity</span> Medical condition

Obesity is a risk factor for many chronic physical and mental illnesses.

In the field of pharmacokinetics, the area under the curve (AUC) is the definite integral of the concentration of a drug in blood plasma as a function of time. In practice, the drug concentration is measured at certain discrete points in time and the trapezoidal rule is used to estimate AUC. In pharmacology, the area under the plot of plasma concentration of a drug versus time after dosage gives insight into the extent of exposure to a drug and its clearance rate from the body.

<span class="mw-page-title-main">Classification of obesity</span> Overview of the classification of the condition of obesity

Obesity classification is a ranking of obesity, the medical condition in which excess body fat has accumulated to the extent that it has an adverse effect on health. The World Health Organization (WHO) classifies obesity by body mass index (BMI). BMI is further evaluated in terms of fat distribution via the waist–hip ratio and total cardiovascular risk factors. In children, a healthy weight varies with age and sex, and obesity determination is in relation to a historical normal group.

<span class="mw-page-title-main">Contrast CT</span> Medical imaging technique

Contrast CT, or contrast enhanced computed tomography (CECT), is X-ray computed tomography (CT) using radiocontrast. Radiocontrasts for X-ray CT are generally iodine-based types. This is useful to highlight structures such as blood vessels that otherwise would be difficult to delineate from their surroundings. Using contrast material can also help to obtain functional information about tissues. Often, images are taken both with and without radiocontrast. CT images are called precontrast or native-phase images before any radiocontrast has been administered, and postcontrast after radiocontrast administration.

<span class="mw-page-title-main">Body shape index</span> Human health index

A Body Shape Index (ABSI) or simply body shape index (BSI) is a metric for assessing the health implications of a given human body height, mass and waist circumference (WC). The inclusion of WC is believed to make the BSI a better indicator of risk of mortality from excess weight than the standard body mass index. ABSI correlates only slightly with height, weight and BMI, indicating that it is independent of other anthropometric variables in predicting mortality.

<span class="mw-page-title-main">Wallace rule of nines</span> Estimate of total body surface area of burns

The Wallace rule of nines is a tool used in pre-hospital and emergency medicine to estimate the total body surface area (BSA) affected by a burn. In addition to determining burn severity, the measurement of burn surface area is important for estimating patients' fluid requirements and determining hospital admission criteria.

The association between obesity, as defined by a body mass index of 30 or higher, and risk of a variety of types of cancer has received a considerable amount of attention in recent years. Obesity has been associated with an increased risk of esophageal cancer, pancreatic cancer, colorectal cancer, breast cancer, endometrial cancer, kidney cancer, thyroid cancer, liver cancer and gallbladder cancer. Obesity may also lead to increased cancer-related mortality. Obesity has also been described as the fat tissue disease version of cancer, where common features between the two diseases were suggested for the first time.

The volume of the heart's left atrium is an important biomarker for cardiovascular physiology and clinical cardiology. It is usually calculated as left atrial volume index in terms of body surface area.

References

  1. Gurney H (April 2002). "How to calculate the dose of chemotherapy". Br. J. Cancer. 86 (8): 1297–302. doi:10.1038/sj.bjc.6600139. PMC   2375356 . PMID   11953888.
  2. Gao B, Klumpen HJ, Gurney H (October 2008). "Dose calculation of anticancer drugs". Expert Opin Drug Metab Toxicol. 4 (10): 1307–19. doi:10.1517/17425255.4.10.1307. PMID   18798700. S2CID   73327796.
  3. Adler, AC; Nathanson, BH; Raguhunathan, K; McGee, WT (2012). "Misleading indexed hemodynamic parameters: the clinical importance of discordant BMI and BSA at extremes of weight". Critical Care. 16 (6): 471. doi: 10.1186/cc11876 . PMC   3672608 . PMID   23273020.
  4. Du Bois D, Du Bois EF (Jun 1916). "A formula to estimate the approximate surface area if height and weight be known". Archives of Internal Medicine. 17 (6): 863–71. doi:10.1001/archinte.1916.00080130010002. Reprinted in PMID   2520314
  5. Verbraecken, J; Van de Heyning P; De Backer W; Van Gaal L (Apr 2006). "Body surface area in normal-weight, overweight, and obese adults. A comparison study". Metabolism: Clinical and Experimental. 55 (4): 515–24. doi:10.1016/j.metabol.2005.11.004. PMID   16546483 . Retrieved 2012-09-07.
  6. Sardinha, LB; Silva, AM; Minderico, CS; Teixeira, PJ (2006). "Effect of body surface area calculations on body fat estimates in non-obese and obese subjects". Physiological Measurement. 27 (11): 1197–209. Bibcode:2006PhyM...27.1197S. doi:10.1088/0967-3334/27/11/012. PMID   17028412. S2CID   12141324.
  7. Mosteller, RD (1987). "Simplified calculation of body-surface area". N Engl J Med . 317 (17): 1098. doi:10.1056/NEJM198710223171717. PMID   3657876.
  8. Haycock, GB; Schwartz, GJ; Wisotsky, DH (1978). "Geometric method for measuring body surface area: A height-weight formula validated in infants, children and adults". J Pediatr. 93 (1): 62–66. doi:10.1016/s0022-3476(78)80601-5. PMID   650346.
  9. Gehan EA, George SL, Cancer Chemother Rep 1970, 54:225-235
  10. Boyd, Edith (1935). The Growth of the Surface Area of the Human Body. University of Minnesota. The Institute of Child Welfare, Monograph Series, No. x. London: Oxford University Press.
  11. 1 2 Fujimoto, S; Watanabe, T; Sakamoto, A; Yukawa, K; Morimoto, K (1968). "Studies on the physical surface area of Japanese. 18. Calculation formulae in three stages over all ages". Nippon Eiseigaku Zasshi. 23 (5): 443–50. doi: 10.1265/jjh.23.443 . PMID   5752712.
  12. Shuter, B; Aslani, A (2000). "Body surface area: Du bois and Du bois revisited". European Journal of Applied Physiology. 82 (3): 250–254. doi:10.1007/s004210050679. PMID   10929220. S2CID   25764872.
  13. Lipscombe, Trevor, Body Surface Area Formula by Use of Geometric Means Medicina Internacia Revuo 2020, 29 (114):11-18
  14. Schlich, E; Schumm, M; Schlich, M (2010). "3-D-Body-Scan als anthropometrisches Verfahren zur Bestimmung der spezifischen Körperoberfläche". Ernährungs Umschau . 57 (4): 178–183.
  15. Costeff H, "A simple empirical formula for calculating approximate surface area in children.," Arch Dis Child, vol. 41, no. 220, pp. 681–683, Dec. 1966.
  16. Furqan, M; Haque, A (December 2009). "Surface area in children: a simple formula". Indian Pediatrics. 46 (12): 1085–7. PMID   19430073.
  17. Georgiev, Georgi. "Body Surface Area Calculator". Gigacalculator.com. Retrieved 17 March 2018.
  18. "National Health and Nutrition Examination Survey". Cdc.gov. Retrieved 2018-03-17.
  19. Sparreboom A, Verweij J (15 Jul 2003). "Paclitaxel Pharmacokinetics, Threshold Models, and Dosing Strategies". Journal of Clinical Oncology. 21 (14): 2803–4. doi: 10.1200/JCO.2003.99.038 . PMID   12860961.
  20. Sacco JJ, Botten J, Macbeth F, Bagust A, Clark P (28 Jan 2010). "The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study". PLoS One . 5 (1): e8933. Bibcode:2010PLoSO...5.8933S. doi: 10.1371/journal.pone.0008933 . PMC   2812484 . PMID   20126669 . Retrieved 2012-09-09.